These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 33853962)

  • 21. Inhibition of KAP1 enhances hypoxia-induced Kaposi's sarcoma-associated herpesvirus reactivation through RBP-Jκ.
    Zhang L; Zhu C; Guo Y; Wei F; Lu J; Qin J; Banerjee S; Wang J; Shang H; Verma SC; Yuan Z; Robertson ES; Cai Q
    J Virol; 2014 Jun; 88(12):6873-84. PubMed ID: 24696491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) lytic replication by human cytomegalovirus.
    Vieira J; O'Hearn P; Kimball L; Chandran B; Corey L
    J Virol; 2001 Feb; 75(3):1378-86. PubMed ID: 11152511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kaposi's Sarcoma-Associated Herpesvirus Nonstructural Membrane Protein pK15 Recruits the Class II Phosphatidylinositol 3-Kinase PI3K-C2α To Activate Productive Viral Replication.
    Abere B; Samarina N; Gramolelli S; Rückert J; Gerold G; Pich A; Schulz TF
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29950425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complex Interactions between Cohesin and CTCF in Regulation of Kaposi's Sarcoma-Associated Herpesvirus Lytic Transcription.
    Li D; Mosbruger T; Verma D; Swaminathan S
    J Virol; 2020 Jan; 94(2):. PubMed ID: 31666380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficient infection of a human B cell line with cell-free Kaposi's sarcoma-associated herpesvirus.
    Dollery SJ; Santiago-Crespo RJ; Kardava L; Moir S; Berger EA
    J Virol; 2014 Feb; 88(3):1748-57. PubMed ID: 24257608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nuclear Innate Immune DNA Sensor IFI16 Is Degraded during Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus (KSHV): Role of IFI16 in Maintenance of KSHV Latency.
    Roy A; Dutta D; Iqbal J; Pisano G; Gjyshi O; Ansari MA; Kumar B; Chandran B
    J Virol; 2016 Oct; 90(19):8822-41. PubMed ID: 27466416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Kaposi's sarcoma-associated herpesvirus (KSHV) non-structural membrane protein K15 is required for viral lytic replication and may represent a therapeutic target.
    Abere B; Mamo TM; Hartmann S; Samarina N; Hage E; Rückert J; Hotop SK; Büsche G; Schulz TF
    PLoS Pathog; 2017 Sep; 13(9):e1006639. PubMed ID: 28938025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of an ORF45-Derived Peptide To Inhibit the Sustained RSK Activation and Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus.
    Li X; Huang L; Xiao Y; Yao X; Long X; Zhu F; Kuang E
    J Virol; 2019 May; 93(10):. PubMed ID: 30842327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spindle cell conversion by Kaposi's sarcoma-associated herpesvirus: formation of colonies and plaques with mixed lytic and latent gene expression in infected primary dermal microvascular endothelial cell cultures.
    Ciufo DM; Cannon JS; Poole LJ; Wu FY; Murray P; Ambinder RF; Hayward GS
    J Virol; 2001 Jun; 75(12):5614-26. PubMed ID: 11356969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracellular-activated Notch1 can reactivate Kaposi's sarcoma-associated herpesvirus from latency.
    Lan K; Murakami M; Choudhuri T; Kuppers DA; Robertson ES
    Virology; 2006 Aug; 351(2):393-403. PubMed ID: 16701788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. KSHV activates unfolded protein response sensors but suppresses downstream transcriptional responses to support lytic replication.
    Johnston BP; Pringle ES; McCormick C
    PLoS Pathog; 2019 Dec; 15(12):e1008185. PubMed ID: 31790507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kaposi's Sarcoma-Associated Herpesvirus Immediate Early Proteins Trigger FOXQ1 Expression in Oral Epithelial Cells, Engaging in a Novel Lytic Cycle-Sustaining Positive Feedback Loop.
    Atyeo N; Chae MY; Toth Z; Sharma A; Papp B
    J Virol; 2023 Mar; 97(3):e0169622. PubMed ID: 36815831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of new antiviral agents against Kaposi's sarcoma-associated herpesvirus (KSHV) by high-throughput drug screening reveals the role of histamine-related signaling in promoting viral lytic reactivation.
    Chen J; Dai L; Goldstein A; Zhang H; Tang W; Forrest JC; Post SR; Chen X; Qin Z
    PLoS Pathog; 2019 Dec; 15(12):e1008156. PubMed ID: 31790497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concurrent Control of the Kaposi's Sarcoma-Associated Herpesvirus Life Cycle through Chromatin Modulation and Host Hedgehog Signaling: a New Prospect for the Therapeutic Potential of Lipoxin A4.
    Asha K; Balfe N; Sharma-Walia N
    J Virol; 2020 Apr; 94(9):. PubMed ID: 32102879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Viral latent proteins as targets for Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) induced lymphoma.
    Staudt MR; Dittmer DP
    Curr Drug Targets Infect Disord; 2003 Jun; 3(2):129-35. PubMed ID: 12769790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling.
    Liang Y; Ganem D
    Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8490-5. PubMed ID: 12832621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of Novel Kaposi's Sarcoma-Associated Herpesvirus Orf50 Transcripts: Discovery of New RTA Isoforms with Variable Transactivation Potential.
    Wakeman BS; Izumiya Y; Speck SH
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficient infection by a recombinant Kaposi's sarcoma-associated herpesvirus cloned in a bacterial artificial chromosome: application for genetic analysis.
    Zhou FC; Zhang YJ; Deng JH; Wang XP; Pan HY; Hettler E; Gao SJ
    J Virol; 2002 Jun; 76(12):6185-96. PubMed ID: 12021352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV-1 Vpr Inhibits Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication by Inducing MicroRNA miR-942-5p and Activating NF-κB Signaling.
    Yan Q; Shen C; Qin J; Li W; Hu M; Lu H; Qin D; Zhu J; Gao SJ; Lu C
    J Virol; 2016 Oct; 90(19):8739-53. PubMed ID: 27440900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. De novo infection and serial transmission of Kaposi's sarcoma-associated herpesvirus in cultured endothelial cells.
    Lagunoff M; Bechtel J; Venetsanakos E; Roy AM; Abbey N; Herndier B; McMahon M; Ganem D
    J Virol; 2002 Mar; 76(5):2440-8. PubMed ID: 11836422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.